Merck Closes Out Canadian Vioxx Claims For Up To $36.5M
Merck & Co. Inc. will pay up to CA$36.9 million (US$36.5 million) to settle a series of Canadian class actions over its marketing of the painkiller Vioxx, which the drugmaker pulled...To view the full article, register now.
Already a subscriber? Click here to view full article